Gain an understanding of evidence-based approaches for treating ADHD and reducing the risk of substance misuse. This webinar examines the role of medication, behavioral therapies, and family-centered interventions in improving outcomes, strengthening protective factors, and supporting long-term health and well-being.

This course provides a comprehensive review of the laws and regulations under the Controlled Substances Act of 1970, which mandate that such substances be prescribed solely for legitimate medical purposes by practitioners operating within the scope of their professional practice.

This course provides a comprehensive review of the laws and regulations under the Controlled Substances Act of 1970, which mandate that such substances be prescribed solely for legitimate medical purposes by practitioners operating within the scope of their professional practice. The course highlights legal requirements related to controlled substances classified in Schedules I through V. Key topics include partial fills, refills, emergency dispensing, and electronic prescribing. It also covers specific regulations applicable to mid-level practitioners and opioid addiction treatment programs.

Correct and complete prescription information is essential to the integrity of the controlled substance database. Incomplete or inaccurate prescription information can result in prescriptions not being transmitted to the controlled substance database, which can cause inaccurate patient records, complications between prescribers and their regulatory boards, and a diminished clinical tool for healthcare providers. During this presentation, Alabama Statute and Administrative Rules related to the Prescription Drug Monitoring Program (PDMP) will be discussed, and the importance of submitting timely and accurate information will be emphasized. This presentation will provide pharmacists and pharmacy technicians with the information needed to successfully submit required prescription information: instructions for establishing a reporting account, the process by which dispensations are submitted, definitions of warning and error, and what fields must be completed to avoid having an error. Lastly, this presentation aims to enhance community pharmacists’ understanding and utilization of the PDMP. By focusing on accurate data entry, effective PDMP use, interstate data sharing, and understanding the Overdose Risk Score (ORS), the session addresses key areas to reduce prescription drug abuse and improve patient care.

This recorded webinar will provide information for primary care providers and pharmacies on how to help patients quit smoking and vaping.

The sale of unregulated and often mislabeled substances—commonly referred to as “gas station drugs”—has expanded rapidly in convenience stores and vape shops. Marketed as legal alternatives or wellness products, these substances often contain psychoactive ingredients that pose significant risks to physical and mental health. This webinar will examine the evolving landscape of gas station drugs, including kratom, delta‑8 and delta- 9 products, and other emerging substances. Participants will learn how these products are marketed, how they are used, and why they present unique challenges for clinicians, educators, and communities. Emphasis will be placed on recognizing signs of misuse, understanding legal and regulatory gaps, and identifying effective prevention and intervention strategies.

Vaping has become one of the most prevalent forms of substance use among adolescents and young adults, driven by appealing flavors, targeted marketing, and widespread misinformation regarding safety. Despite its popularity, vaping is associated with significant respiratory, cardiovascular, and neurological risks, as well as an increased likelihood of transitioning to other substance use. This webinar will explore current trends in vaping, including nicotine and THC products, their health impacts, and the unique vulnerabilities of youth populations. Participants will gain insight into effective screening methods, counseling approaches, and prevention strategies.